desmethylcyproheptadine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-1993
01219831993

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
To investigate the pharmacokinetics of cyproheptadine (CPH) and its metabolites, the plasma concentration and urinary excretion… (More)
Is this relevant?
1991
1991
The relationship between age-related differences in cyproheptadine (CPH)-induced alteration of endocrine pancreas function and… (More)
Is this relevant?
1991
1991
Pretreatment with an oral dose (45 mg/kg) of cyproheptadine (CPH), a drug that inhibits secretion and synthesis of insulin. 3 hr… (More)
Is this relevant?
1989
1989
The contribution of drug metabolites to cyproheptadine (CPH)-induced alterations in endocrine pancreatic β-cells was investigated… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1988
1988
The effects of pretreatment with inhibitors of drug metabolism on the biotransformation of cyproheptadine (CPH) and the ability… (More)
Is this relevant?
1987
1987
The tissue distribution of unchanged drug and metabolites in pregnant rats was studied following oral administration of… (More)
Is this relevant?
1986
1986
The susceptibility of fetal endocrine pancreas to the diabetogenic action of cyproheptadine was investigated. Cyproheptadine (5… (More)
Is this relevant?
1985
1985
The role of a direct effect of serotonin (5-HT) on PRL secretion at the pituitary level is uncertain. The present study… (More)
Is this relevant?
1983
1983
Cyproheptadine and its metabolite desmethylcyproheptadine were shown to suppress directly the release of adrenocorticotrophin… (More)
Is this relevant?
1983
1983
The effects of cyproheptadine, desmethylcyproheptadine, serotonin, gamma-amino-butyric acid (GABA) and sodium valproate were… (More)
Is this relevant?